These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38395973)
1. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors. Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973 [TBL] [Abstract][Full Text] [Related]
2. A preoperative computed tomography radiomics model to predict disease-free survival in patients with pancreatic neuroendocrine tumors. Homps M; Soyer P; Coriat R; Dermine S; Pellat A; Fuks D; Marchese U; Terris B; Groussin L; Dohan A; Barat M Eur J Endocrinol; 2023 Oct; 189(4):476-484. PubMed ID: 37787635 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasms. Park HJ; Kim HJ; Kim JH; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM Eur Radiol; 2023 Apr; 33(4):2713-2724. PubMed ID: 36378252 [TBL] [Abstract][Full Text] [Related]
4. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features. Park HJ; Park B; Park SY; Choi SH; Rhee H; Park JH; Cho ES; Yeom SK; Park S; Park MS; Lee SS Eur Radiol; 2021 Nov; 31(11):8638-8648. PubMed ID: 33890153 [TBL] [Abstract][Full Text] [Related]
5. Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model. Ahmed TM; Zhu Z; Yasrab M; Blanco A; Kawamoto S; He J; Fishman EK; Chu L; Javed AA Ann Surg Oncol; 2024 Nov; 31(12):8136-8145. PubMed ID: 39179862 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study. Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772 [TBL] [Abstract][Full Text] [Related]
7. Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors. Pulvirenti A; Javed AA; Landoni L; Jamieson NB; Chou JF; Miotto M; He J; Gonen M; Pea A; Tang LH; Nessi C; Cingarlini S; D'Angelica MI; Gill AJ; Kingham TP; Scarpa A; Weiss MJ; Balachandran VP; Samra JS; Cameron JL; Jarnagin WR; Salvia R; Wolfgang CL; Allen PJ; Bassiy C Ann Surg; 2021 Dec; 274(6):1051-1057. PubMed ID: 31567347 [TBL] [Abstract][Full Text] [Related]
8. A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors. Wang WQ; Zhang WH; Gao HL; Huang D; Xu HX; Li S; Li TJ; Xu SS; Li H; Long J; Ye LY; Wu CT; Han X; Wang XH; Liu L; Yu XJ J Gastroenterol; 2021 Apr; 56(4):395-405. PubMed ID: 33742253 [TBL] [Abstract][Full Text] [Related]
9. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease. Lopez-Aguiar AG; Ethun CG; Postlewait LM; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK; Cardona K Ann Surg Oncol; 2018 Jan; 25(1):290-298. PubMed ID: 29079920 [TBL] [Abstract][Full Text] [Related]
10. A novel model for predicting postoperative liver metastasis in R0 resected pancreatic neuroendocrine tumors: integrating computational pathology and deep learning-radiomics. Ma M; Gu W; Liang Y; Han X; Zhang M; Xu M; Gao H; Tang W; Huang D J Transl Med; 2024 Aug; 22(1):768. PubMed ID: 39143624 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection. Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171 [TBL] [Abstract][Full Text] [Related]
12. Survival prediction after upfront surgery in patients with pancreatic ductal adenocarcinoma: Radiomic, clinic-pathologic and body composition analysis. Shi H; Wei Y; Cheng S; Lu Z; Zhang K; Jiang K; Xu Q Pancreatology; 2021 Jun; 21(4):731-737. PubMed ID: 33678581 [TBL] [Abstract][Full Text] [Related]
13. Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions. Cingarlini S; Ortolani S; Salgarello M; Butturini G; Malpaga A; Malfatti V; DʼOnofrio M; Davì MV; Vallerio P; Ruzzenente A; Capelli P; Citton E; Grego E; Trentin C; De Robertis R; Scarpa A; Bassi C; Tortora G Pancreas; 2017 Jan; 46(1):42-47. PubMed ID: 27906872 [TBL] [Abstract][Full Text] [Related]
14. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study. Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324 [TBL] [Abstract][Full Text] [Related]
15. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features. Mori M; Palumbo D; Muffatti F; Partelli S; Mushtaq J; Andreasi V; Prato F; Ubeira MG; Palazzo G; Falconi M; Fiorino C; De Cobelli F Eur Radiol; 2023 Jun; 33(6):4412-4421. PubMed ID: 36547673 [TBL] [Abstract][Full Text] [Related]
16. Preoperative Prediction of G1 and G2/3 Grades in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors Using Multimodality Imaging. Liu C; Bian Y; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Lu J; Xu J; Shao C Acad Radiol; 2022 Apr; 29(4):e49-e60. PubMed ID: 34175209 [TBL] [Abstract][Full Text] [Related]
17. Computed Tomography Features Predictive of Lymph Node Involvement in Patients With a Nonfunctioning Pancreatic Neuroendocrine Tumor. Choi SH; Kim HJ; Kim SY; Byun JH; Kim KW; Song KB; Kim SC; Kim MH Pancreas; 2017 Sep; 46(8):1056-1063. PubMed ID: 28787330 [TBL] [Abstract][Full Text] [Related]
18. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics. Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158 [TBL] [Abstract][Full Text] [Related]
19. Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors. Zhang WH; Wang WQ; Han X; Gao HL; Xu SS; Li S; Li TJ; Xu HX; Li H; Ye LY; Lin X; Wu CT; Long J; Yu XJ; Liu L J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33055204 [TBL] [Abstract][Full Text] [Related]
20. A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study. Nie P; Yang G; Wang Y; Xu Y; Yan L; Zhang M; Zhao L; Wang N; Zhao X; Li X; Cheng N; Wang Y; Chen C; Wang N; Duan S; Wang X; Wang Z Eur Radiol; 2023 Dec; 33(12):8858-8868. PubMed ID: 37389608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]